SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
biotech fireworks
An SI Board Since October 2001
Posts SubjectMarks Bans
7424 222 0
Emcee:  nigel bates Type:  Unmoderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
5324MDVN: got hit: $13 stox now after 27 decline in PPS. ONLY other Phase 2 trial ismlkr-3/4/2010
5323Peter is obviously smarter than me. You had to bring up r-flurbiprofen! I was ikenhott-3/3/2010
5322Ouch... you actually owned the sucker? Peter too, but he got out before the crscaram(o)uche-3/3/2010
5321Reply- Thanks for the hankie. Can't win them all. At least I knew enough tkenhott-3/3/2010
5320businesswire.com ...In the CONNECTION trial, dimebon did not meet its co-primarBiotech Jim-3/3/2010
5319Bombed. Someone delete these posts. :) Maybe more like. :(kenhott-3/3/2010
5318Scaram beat me to it but... Medivation to Host Conference Call at 8:30 a.m. Easkenhott-3/2/2010
5317APPA; on rise with pending march 18 date; $2.00 -- almost 52 weeks high figure! mlkr-3/2/2010
5316Questcor (QCOR) up 20% on good earnings. Only saw an estimate for the year (nottuck-3/2/2010
5315And now a settlement of a class action lawsuit and an upgrade sends Sequenom (SQtuck-3/2/2010
5314CombinatoRx gets Exalgo approval, shares up almost 40%. Message 26356156 Cheertuck-3/2/2010
5313HALO up 19% on speculation it also could become a takeover target after BAX.N saidos-3/1/2010
5312OSIP currently up ~46% premarket as Astellas offers to buy the company for $52/sBiotech Jim-3/1/2010
5311Molecular Insight (MIPI) up over 50% on no news. Am hearing of buyout rumors. tuck-2/18/2010
5310Here's one for the efficient market theory - CYCC on what looks like last wtom pope-2/17/2010
5309From the same BioMedReports write-up: ›› Zoraxel for erectile dysfunction is a DewDiligence_on_SI-2/16/2010
5308RNN rise of the past few days may have been sparked by the silly sounding reportpeter michaelson-2/16/2010
5307Sequenom (SQNM) launches fetal sex determination test, launching price a good 16tuck-2/16/2010
5306Genvec (GNVC) made it today: 17%, no additional news. Cheers, Tucktuck-2/16/2010
5305Well, then we have an outlier: Rexahn (RNN) up almost 24% today, too, on no addtuck-2/16/2010
5304Done - CYCC (CYCLACEL)tom pope-2/13/2010
5303SNSS: Jeffs upped it with price target of 1.50-2.00.Closed around 1.07 over 8 m mlkr-2/13/2010
5302Fair point tom. It's just that the thread is threatening to degenerate intonigel bates12/13/2010
5301Will do tomorrow though I'd like a savvy person to write the intro. Anyone?tom pope-2/12/2010
5300There seems to be enough interest in CYCC to justify its own thread. I'd sttuck-2/12/2010
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News